Cargando…
Tackling variants with antibodies
Antibodies targeting the protein that causes placental malaria can recognise multiple variants of the protein, which may help guide the development of new vaccines to protect pregnant women from malaria.
Autores principales: | Aitken, Elizabeth H, Rogerson, Stephen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959596/ https://www.ncbi.nlm.nih.gov/pubmed/35344481 http://dx.doi.org/10.7554/eLife.77751 |
Ejemplares similares
-
Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria
por: Aitken, Elizabeth H, et al.
Publicado: (2021) -
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020) -
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
por: Doritchamou, Justin YA, et al.
Publicado: (2022) -
Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory
por: Burton, Bronwen R, et al.
Publicado: (2018) -
Beyond Binding: The Outcomes of Antibody-Dependent Complement Activation in Human Malaria
por: Rathnayake, Dilini, et al.
Publicado: (2021)